Nancy Thornberry
Director · Denali Therapeutics Inc.
IndividualSelling only2 10b5-1 trades
- 2026
- Sep 4, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Thornberry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
- Peter Scott Chin - $37K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nancy Thornberry?
Nancy Thornberry is a corporate insider, tracked as Director of Denali Therapeutics Inc. (DNLI). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy Thornberry submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Nancy Thornberry been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($262K) across all tracked filings.
